Grab Stock And 2 Penny Stocks With Stronger Balance Sheets

Penny stocks can look risky at first glance, but the Financially Fit Penny Stocks screener focuses on companies trading below 5 that also show signs of stronger balance sheets and healthier cash positions than many early stage peers. With inflation trends mixed across major economies, central banks reassessing policy paths, and energy and trade tensions keeping markets jumpy, some investors are looking for smaller stocks where company specific progress matters more than broad index swings. This article highlights 3 of the better candidates from that screener, explaining why they stand out on financial quality without stretching your risk tolerance too far.

Grab Holdings (GRAB)

Overview: Grab Holdings runs a superapp across Southeast Asia that pulls together ride-hailing, food and grocery delivery, digital payments, and banking-style services so consumers, drivers, and merchants can transact through a single platform.

Operations: Grab generates most of its revenue from Deliveries at US$1.9b and Mobility at US$1.3b, with smaller contributions from Financial Services at US$379m and Other activities at US$4m.

Market Cap: US$15.5b

Grab Holdings stands out in the penny stock space because it combines a broad superapp footprint with improving profitability, rising net margins, and a balance sheet that relies on external funding but supports expansion in payments and banking through assets like Superbank in Indonesia. Analysts expect strong earnings growth and see a wide gap between the current share price and their fair value estimates, even though the stock’s P/E is high relative to many peers. At the same time, high non cash earnings, a funding mix dependent on borrowings, and recent insider selling by the CEO keep the risk profile real. This is exactly why a closer look at Grab’s quality signals and vulnerabilities matters for investors hunting for financially fitter penny stocks.

Grab’s superapp story is all about scale meeting improving profitability, but the real question is how far that can go before funding and insider moves start to matter more. Get the 4 key rewards and 1 important major warning sign

Clover Health Investments (CLOV)

Overview: Clover Health Investments provides Medicare Advantage insurance plans to eligible individuals in the United States and supports physicians with its Clover Assistant software platform, which helps identify and manage chronic diseases using data driven insights.

Operations: Clover Health Investments generates all of its US$2.2b in revenue from Insurance operations in the United States.

Market Cap: US$2.5b

Clover Health Investments catches the eye because it combines a technology supported Medicare Advantage model with a business that is still reporting net losses but is forecast to move toward profitability, with revenue and earnings growth projections well ahead of the wider US market. The stock trades on low P/S ratios compared with many healthcare peers, while analysts see room for the business to improve margins as cost controls, operating leverage and a 4 star rating on PPO plans support higher reimbursement. At the same time, rising medical and pharmacy costs, regulatory shifts and reliance on Medicare Advantage policy settings mean investors need to weigh funding risk, insider selling and future reimbursement decisions carefully before leaning into the story.

Clover Health’s push toward profitability with data driven Medicare Advantage plans is only half the story, and the full risk reward picture may surprise you when you read the analyst forecasts for Clover Health Investments

Hyliion Holdings (HYLN)

Overview: Hyliion Holdings develops the KARNO Power Module, a fuel flexible generator that can produce electricity from conventional fuels, waste gases, or zero carbon options like hydrogen and ammonia, targeting distributed power needs for data centers, defense and other mission critical applications.

Operations: Hyliion generates US$5.8m in revenue from Auto Parts & Accessories in the United States.

Market Cap: US$729.4m

Hyliion Holdings is drawing attention because the KARNO Power Module aims to address power needs for AI data centers and defense projects that require reliable, lower emission on site power. Funded sea trials on a US Navy unmanned vessel and multi fuel demonstrations highlight practical use cases. At the same time, Hyliion is still pre commercial, reporting a loss of US$11.74m in Q1 2026 and relying on a cash balance that implies less than a year of runway if commercialization is delayed. Short seller criticism over a large letter of intent, rising executive pay and heavy dependence on additive manufacturing keeps the risk profile high. These factors frame the core question for investors evaluating Hyliion’s KARNO story.

Hyliion’s KARNO story is accelerating, but the real tension sits between that US$11.74m quarterly loss, the limited cash runway and what happens if commercialization timing shifts. Get the 1 key reward and 3 important warning signs (2 are major!)

The three stocks here are just a sampler, and the full Financially Fit Penny Stocks screener has surfaced 324 more companies with equally compelling financial stories and potential catalysts inside the Financially Fit Penny Stocks screener. Use Simply Wall St to identify, filter and analyze the specific balance sheet strength, earnings drivers and risk flags that match your playbook so you can focus on the highest conviction ideas in the group.

Take Control of Your Investment Journey

If Clover Health Investments or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives For Your Curiosity?

New stock stories can move from quiet to breakout territory fast. Once momentum is strong, early entry may no longer be available, so consider acting before the crowd.

• Spot cash rich businesses that are staying resilient through stress and explore the curated list of solid balance sheet and fundamentals (48 results) while these under the radar picks are still priced for caution.
• Consider the expanding demand for AI infrastructure and review companies powering the hardware backbone with the focused 52 AI infrastructure stocks before any strongest trends may be fully reflected in prices.
• Target long term income potential and scan dependable payers in the curated 10 dividend fortresses while yields remain elevated and prices have not yet fully rebounded.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com